Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	proteoglycan binding	CFHR4 SLIT1 LRP1 CTSK CTSL CTSV	2.03e-07	51	100	6	GO:0043394
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor activity	VLDLR LRP1B STAB1 LRP1	1.03e-06	16	100	4	GO:0005041
GeneOntologyMolecularFunction	demethylase activity	CYP1A2 KDM3A KDM3B KDM6A UTY	2.65e-06	44	100	5	GO:0032451
GeneOntologyMolecularFunction	lipoprotein particle receptor activity	VLDLR LRP1B STAB1 LRP1	3.32e-06	21	100	4	GO:0030228
GeneOntologyMolecularFunction	cysteine-type endopeptidase activity	USP6 CTSK CTSL CTSV CTSW USP33	4.61e-06	86	100	6	GO:0004197
GeneOntologyMolecularFunction	histone H3 demethylase activity	KDM3A KDM3B KDM6A UTY	1.11e-05	28	100	4	GO:0141052
GeneOntologyMolecularFunction	histone demethylase activity	KDM3A KDM3B KDM6A UTY	1.68e-05	31	100	4	GO:0032452
GeneOntologyMolecularFunction	protein demethylase activity	KDM3A KDM3B KDM6A UTY	1.91e-05	32	100	4	GO:0140457
GeneOntologyMolecularFunction	serpin family protein binding	CTSL CTSV	2.48e-05	2	100	2	GO:0097655
GeneOntologyMolecularFunction	miRNA binding	RBM10 AGO1 AGO4 ZC3H7B	9.73e-05	48	100	4	GO:0035198
GeneOntologyMolecularFunction	cysteine-type carboxypeptidase activity	CTSL CTSV	1.48e-04	4	100	2	GO:0016807
GeneOntologyMolecularFunction	histone modifying activity	KDM3A KDM3B PRDM8 KMT5B PRDM16 KDM6A UTY	1.54e-04	229	100	7	GO:0140993
GeneOntologyMolecularFunction	sulfur compound binding	OGDH METTL14 CFHR4 CFHR3 KMT5B SLIT1 LRP1 LTF	2.20e-04	323	100	8	GO:1901681
GeneOntologyMolecularFunction	kininogen binding	CTSL CTSV	2.46e-04	5	100	2	GO:0030984
GeneOntologyMolecularFunction	histone H3K27me2/H3K27me3 demethylase activity	KDM6A UTY	2.46e-04	5	100	2	GO:0071558
GeneOntologyMolecularFunction	histone H3K9me/H3K9me2 demethylase activity	KDM3A KDM3B	2.46e-04	5	100	2	GO:0140683
GeneOntologyMolecularFunction	regulatory RNA binding	RBM10 AGO1 AGO4 ZC3H7B	2.64e-04	62	100	4	GO:0061980
GeneOntologyMolecularFunction	2-oxoglutarate-dependent dioxygenase activity	KDM3A KDM3B KDM6A UTY	3.17e-04	65	100	4	GO:0016706
GeneOntologyMolecularFunction	heparan sulfate proteoglycan binding	CFHR4 SLIT1 LRP1	4.05e-04	29	100	3	GO:0043395
GeneOntologyMolecularFunction	cysteine-type endopeptidase activator activity involved in apoptotic process	CTSK CTSL CTSV	4.05e-04	29	100	3	GO:0008656
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP6 CTSK CTSL CTSV CTSW USP33	4.12e-04	192	100	6	GO:0008234
GeneOntologyMolecularFunction	peptidase activator activity involved in apoptotic process	CTSK CTSL CTSV	5.44e-04	32	100	3	GO:0016505
GeneOntologyMolecularFunction	complement binding	CFHR4 CFHR3 C3AR1	5.44e-04	32	100	3	GO:0001848
GeneOntologyMolecularFunction	collagen binding	MRC2 CTSK CTSL CTSV	7.33e-04	81	100	4	GO:0005518
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor	PDHA1 OGDH	8.74e-04	9	100	2	GO:0016624
GeneOntologyMolecularFunction	cargo receptor activity	VLDLR LRP1B STAB1 LRP1	8.79e-04	85	100	4	GO:0038024
GeneOntologyMolecularFunction	fibronectin binding	CTSK CTSL CTSV	9.05e-04	38	100	3	GO:0001968
GeneOntologyMolecularFunction	cysteine-type exopeptidase activity	CTSL CTSV	1.09e-03	10	100	2	GO:0070004
GeneOntologyMolecularFunction	dioxygenase activity	KDM3A KDM3B KDM6A UTY	1.49e-03	98	100	4	GO:0051213
GeneOntologyMolecularFunction	complement component C3b binding	CFHR4 CFHR3	1.59e-03	12	100	2	GO:0001851
GeneOntologyMolecularFunction	lipopolysaccharide binding	ADGRB1 PTAFR LTF	1.79e-03	48	100	3	GO:0001530
GeneOntologyMolecularFunction	histone H3K9 methyltransferase activity	PRDM8 PRDM16	1.87e-03	13	100	2	GO:0046974
GeneOntologyMolecularFunction	histone H3K9 demethylase activity	KDM3A KDM3B	2.17e-03	14	100	2	GO:0032454
GeneOntologyMolecularFunction	immunoglobulin receptor activity	FCER2 PIGR	2.17e-03	14	100	2	GO:0019763
GeneOntologyMolecularFunction	cysteine-type endopeptidase regulator activity involved in apoptotic process	CTSK CTSL CTSV	2.51e-03	54	100	3	GO:0043028
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	CYP1A2 KDM3A KDM3B KDM6A UTY	2.94e-03	194	100	5	GO:0016705
GeneOntologyMolecularFunction	methyltransferase activity	TYW3 METTL14 PRDM8 KMT5B PRDM16	4.37e-03	213	100	5	GO:0008168
GeneOntologyMolecularFunction	apolipoprotein binding	VLDLR LRP1	4.45e-03	20	100	2	GO:0034185
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	PRDM8 KMT5B PRDM16	4.83e-03	68	100	3	GO:0016279
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	PRDM8 KMT5B PRDM16	5.03e-03	69	100	3	GO:0016278
GeneOntologyMolecularFunction	peptidase activator activity	CTSK CTSL CTSV	5.23e-03	70	100	3	GO:0016504
GeneOntologyMolecularFunction	transferase activity, transferring one-carbon groups	TYW3 METTL14 PRDM8 KMT5B PRDM16	5.40e-03	224	100	5	GO:0016741
GeneOntologyMolecularFunction	histone methyltransferase activity	PRDM8 KMT5B PRDM16	5.44e-03	71	100	3	GO:0042054
GeneOntologyMolecularFunction	S-adenosyl-L-methionine binding	METTL14 KMT5B	5.87e-03	23	100	2	GO:1904047
GeneOntologyMolecularFunction	endopeptidase activity	USP6 LTF CTSK CTSL CTSV CTSW USP33	5.88e-03	430	100	7	GO:0004175
GeneOntologyMolecularFunction	opsonin binding	CFHR4 CFHR3	6.91e-03	25	100	2	GO:0001846
GeneOntologyBiologicalProcess	endocytosis	VLDLR ADGRB1 LRP1B STAB1 USP6 FCER2 MRC2 MIB1 MKLN1 LRP1 C4BPA VAV3 LY75 CTSL USP33	1.32e-05	827	102	15	GO:0006897
GeneOntologyBiologicalProcess	positive regulation of transcytosis	PTAFR LRP1	2.42e-05	2	102	2	GO:1904300
GeneOntologyBiologicalProcess	regulation of transcytosis	PTAFR LRP1	2.42e-05	2	102	2	GO:1904298
GeneOntologyCellularComponent	vacuole	VLDLR TTC3 PGAP6 USP6 STS PIGR MTOR LRP1 C3AR1 C4BPA CTSK CTSL CTSV CTSW	1.71e-04	913	104	14	GO:0005773
GeneOntologyCellularComponent	endolysosome lumen	CTSK CTSL	2.43e-04	5	104	2	GO:0036021
GeneOntologyCellularComponent	elongator holoenzyme complex	ELP1 ELP2	3.63e-04	6	104	2	GO:0033588
GeneOntologyCellularComponent	cell surface	VLDLR TNFRSF4 CFHR4 FCER2 MSLNL MRC2 LRP1 ROS1 LTF SLITRK6 LY75 CTSK CTSL CTSV KLRB1	3.89e-04	1111	104	15	GO:0009986
GeneOntologyCellularComponent	lysosome	VLDLR PGAP6 USP6 STS PIGR MTOR LRP1 C3AR1 CTSK CTSL CTSV CTSW	7.03e-04	811	104	12	GO:0005764
GeneOntologyCellularComponent	lytic vacuole	VLDLR PGAP6 USP6 STS PIGR MTOR LRP1 C3AR1 CTSK CTSL CTSV CTSW	7.03e-04	811	104	12	GO:0000323
GeneOntologyCellularComponent	RISC-loading complex	AGO1 AGO4	1.07e-03	10	104	2	GO:0070578
GeneOntologyCellularComponent	external side of plasma membrane	TNFRSF4 CFHR4 FCER2 LRP1 LY75 CTSK CTSL CTSV KLRB1	1.14e-03	519	104	9	GO:0009897
GeneOntologyCellularComponent	MLL3/4 complex	KDM6A UTY	1.57e-03	12	104	2	GO:0044666
MousePheno	excessive scratching	ELP1 PRDM8 CTSL CTSV	1.90e-06	15	88	4	MP:0001412
MousePheno	periodontal ligament necrosis	CTSL CTSV	3.92e-05	2	88	2	MP:0030515
MousePheno	abnormal lymph node medullary sinus morphology	CTSL CTSV	3.92e-05	2	88	2	MP:0011222
MousePheno	dilated lymph node medullary sinus	CTSL CTSV	3.92e-05	2	88	2	MP:0011223
MousePheno	amyloidosis	CFHR4 CTSK CTSL CTSV	6.61e-05	35	88	4	MP:0000604
MousePheno	abnormal amyloid deposition	CFHR4 CTSK CTSL CTSV	6.61e-05	35	88	4	MP:0021152
Domain	EGF	VLDLR ZAN LRP1B STAB1 EYS FAT1 NRXN3 JAG1 SLIT1 LRP1	1.89e-09	126	103	10	PF00008
Domain	EGF	VLDLR FRAS1 ZAN LRP1B PGAP6 STAB1 EYS FAT1 NRXN3 JAG1 SLIT1 LRP1	6.63e-09	235	103	12	SM00181
Domain	EGF-like_dom	VLDLR FRAS1 ZAN LRP1B PGAP6 STAB1 EYS FAT1 NRXN3 JAG1 SLIT1 LRP1	1.27e-08	249	103	12	IPR000742
Domain	Growth_fac_rcpt_	VLDLR FRAS1 LRP1B STAB1 EYS FAT1 IGFBP2 JAG1 SLIT1 LRP1	1.50e-08	156	103	10	IPR009030
Domain	Inhibitor_I29	CTSK CTSL CTSV CTSW	3.01e-08	7	103	4	PF08246
Domain	Prot_inhib_I29	CTSK CTSL CTSV CTSW	3.01e-08	7	103	4	IPR013201
Domain	Inhibitor_I29	CTSK CTSL CTSV CTSW	3.01e-08	7	103	4	SM00848
Domain	EGF_3	VLDLR ZAN LRP1B PGAP6 STAB1 EYS FAT1 NRXN3 JAG1 SLIT1 LRP1	7.14e-08	235	103	11	PS50026
Domain	EGF-type_Asp/Asn_hydroxyl_site	VLDLR LRP1B EYS FAT1 NRXN3 JAG1 SLIT1 LRP1	1.25e-07	106	103	8	IPR000152
Domain	EGF_1	VLDLR ZAN LRP1B PGAP6 STAB1 EYS FAT1 NRXN3 JAG1 SLIT1 LRP1	1.63e-07	255	103	11	PS00022
Domain	Pept_asp_AS	CTSK CTSL CTSV CTSW	1.79e-07	10	103	4	IPR025661
Domain	EGF-like_CS	VLDLR ZAN LRP1B PGAP6 STAB1 EYS FAT1 NRXN3 JAG1 SLIT1 LRP1	2.06e-07	261	103	11	IPR013032
Domain	EGF_2	VLDLR ZAN LRP1B PGAP6 STAB1 EYS FAT1 NRXN3 JAG1 SLIT1 LRP1	2.40e-07	265	103	11	PS01186
Domain	Pept_his_AS	CTSK CTSL CTSV CTSW	2.79e-07	11	103	4	IPR025660
Domain	EGF_CA	VLDLR LRP1B STAB1 EYS FAT1 JAG1 SLIT1 LRP1	3.72e-07	122	103	8	SM00179
Domain	EGF-like_Ca-bd_dom	VLDLR LRP1B STAB1 EYS FAT1 JAG1 SLIT1 LRP1	4.22e-07	124	103	8	IPR001881
Domain	Pept_C1	CTSK CTSL CTSV CTSW	6.00e-07	13	103	4	SM00645
Domain	Peptidase_C1A_C	CTSK CTSL CTSV CTSW	6.00e-07	13	103	4	IPR000668
Domain	Peptidase_C1	CTSK CTSL CTSV CTSW	6.00e-07	13	103	4	PF00112
Domain	Peptidase_C1A	CTSK CTSL CTSV CTSW	6.00e-07	13	103	4	IPR013128
Domain	EGF_Ca-bd_CS	VLDLR LRP1B EYS FAT1 JAG1 SLIT1 LRP1	1.08e-06	97	103	7	IPR018097
Domain	LY	VLDLR LRP1B LRP1 ROS1	1.14e-06	15	103	4	SM00135
Domain	LDLR_classB_rpt	VLDLR LRP1B LRP1 ROS1	1.14e-06	15	103	4	IPR000033
Domain	EGF_CA	VLDLR LRP1B EYS FAT1 JAG1 SLIT1 LRP1	1.24e-06	99	103	7	PS01187
Domain	ASX_HYDROXYL	VLDLR LRP1B EYS FAT1 NRXN3 JAG1 LRP1	1.33e-06	100	103	7	PS00010
Domain	-	VLDLR ELP1 LRP1B LRP1 ROS1	2.29e-06	39	103	5	2.120.10.30
Domain	6-blade_b-propeller_TolB-like	VLDLR ELP1 LRP1B LRP1 ROS1	5.30e-06	46	103	5	IPR011042
Domain	JmjC	KDM3A KDM3B KDM6A UTY	8.51e-06	24	103	4	PF02373
Domain	THIOL_PROTEASE_CYS	CTSK CTSL CTSV CTSW	1.19e-05	26	103	4	PS00139
Domain	THIOL_PROTEASE_ASN	CTSK CTSL CTSV CTSW	1.39e-05	27	103	4	PS00640
Domain	THIOL_PROTEASE_HIS	CTSK CTSL CTSV CTSW	1.39e-05	27	103	4	PS00639
Domain	Pept_cys_AS	CTSK CTSL CTSV CTSW	1.61e-05	28	103	4	IPR000169
Domain	JMJC	KDM3A KDM3B KDM6A UTY	2.79e-05	32	103	4	PS51184
Domain	JmjC_dom	KDM3A KDM3B KDM6A UTY	2.79e-05	32	103	4	IPR003347
Domain	DUF5050	LRP1B LRP1	3.01e-05	2	103	2	IPR032485
Domain	DUF5050	LRP1B LRP1	3.01e-05	2	103	2	PF16472
Domain	JmjC	KDM3A KDM3B KDM6A UTY	3.16e-05	33	103	4	SM00558
Domain	LAM_G_DOMAIN	EYS FAT1 NRXN3 SLIT1	5.57e-05	38	103	4	PS50025
Domain	Ldl_recept_b	VLDLR LRP1B LRP1	5.67e-05	14	103	3	PF00058
Domain	LDLRB	VLDLR LRP1B LRP1	5.67e-05	14	103	3	PS51120
Domain	Laminin_G_2	EYS FAT1 NRXN3 SLIT1	6.84e-05	40	103	4	PF02210
Domain	LamG	EYS FAT1 NRXN3 SLIT1	9.99e-05	44	103	4	SM00282
Domain	EGF_CA	VLDLR LRP1B FAT1 JAG1 LRP1	1.13e-04	86	103	5	PF07645
Domain	VWC_out	FRAS1 ZAN JAG1	1.48e-04	19	103	3	SM00215
Domain	Argonaute_N	AGO1 AGO4	1.79e-04	4	103	2	IPR032474
Domain	Argonaute_Mid_dom	AGO1 AGO4	1.79e-04	4	103	2	IPR032473
Domain	ArgoL2	AGO1 AGO4	1.79e-04	4	103	2	IPR032472
Domain	ArgoN	AGO1 AGO4	1.79e-04	4	103	2	PF16486
Domain	ArgoMid	AGO1 AGO4	1.79e-04	4	103	2	PF16487
Domain	ArgoL2	AGO1 AGO4	1.79e-04	4	103	2	PF16488
Domain	C-type_lectin-like/link	STAB1 FCER2 MRC2 LY75 KLRB1	2.19e-04	99	103	5	IPR016186
Domain	Laminin_G	EYS FAT1 NRXN3 SLIT1	2.94e-04	58	103	4	IPR001791
Domain	DUF1785	AGO1 AGO4	2.98e-04	5	103	2	SM01163
Domain	CTDL_fold	STAB1 FCER2 MRC2 LY75 KLRB1	3.15e-04	107	103	5	IPR016187
Domain	ArgoL1	AGO1 AGO4	4.45e-04	6	103	2	PF08699
Domain	ArgoL1	AGO1 AGO4	4.45e-04	6	103	2	IPR014811
Domain	E1_dh	PDHA1 OGDH	4.45e-04	6	103	2	PF00676
Domain	DH_E1	PDHA1 OGDH	4.45e-04	6	103	2	IPR001017
Domain	hEGF	EYS JAG1 SLIT1	4.83e-04	28	103	3	PF12661
Domain	LRRCT	CHAD SLIT1 SLITRK6	7.19e-04	32	103	3	PF01463
Domain	PIWI	AGO1 AGO4	8.25e-04	8	103	2	PS50822
Domain	Piwi	AGO1 AGO4	8.25e-04	8	103	2	SM00950
Domain	Piwi	AGO1 AGO4	8.25e-04	8	103	2	IPR003165
Domain	Piwi	AGO1 AGO4	8.25e-04	8	103	2	PF02171
Domain	C_TYPE_LECTIN_1	FCER2 MRC2 LY75 KLRB1	1.00e-03	80	103	4	PS00615
Domain	-	NRDE2 TTC3 MTOR ZC3H7B KDM6A UTY	1.01e-03	207	103	6	1.25.40.10
Domain	PAZ	AGO1 AGO4	1.06e-03	9	103	2	PS50821
Domain	PAZ	AGO1 AGO4	1.06e-03	9	103	2	SM00949
Domain	PAZ_dom	AGO1 AGO4	1.06e-03	9	103	2	IPR003100
Domain	PAZ	AGO1 AGO4	1.06e-03	9	103	2	PF02170
Domain	ZF_RING_1	UBR1 TTC3 RNF157 MIB1 NFXL1 RNF180 OBI1	1.15e-03	291	103	7	PS00518
Domain	VWC	FRAS1 ZAN JAG1	1.19e-03	38	103	3	SM00214
Domain	Lectin_C	FCER2 MRC2 LY75 KLRB1	1.20e-03	84	103	4	PF00059
Domain	CLECT	FCER2 MRC2 LY75 KLRB1	1.20e-03	84	103	4	SM00034
Domain	C_TYPE_LECTIN_2	FCER2 MRC2 LY75 KLRB1	1.25e-03	85	103	4	PS50041
Domain	C-type_lectin-like	FCER2 MRC2 LY75 KLRB1	1.31e-03	86	103	4	IPR001304
Domain	ZF_RING_2	UBR1 TTC3 RNF157 MIB1 NFXL1 RNF180 OBI1	1.32e-03	298	103	7	PS50089
Domain	LDLR_class-A_CS	VLDLR LRP1B LRP1	1.39e-03	40	103	3	IPR023415
Domain	Cys-rich_flank_reg_C	CHAD LRRC70 SLIT1 SLITRK6	1.55e-03	90	103	4	IPR000483
Domain	TPR_1	TTC3 ZC3H7B KDM6A UTY	1.55e-03	90	103	4	PF00515
Domain	TPR_1	TTC3 ZC3H7B KDM6A UTY	1.55e-03	90	103	4	IPR001440
Domain	LRRCT	CHAD LRRC70 SLIT1 SLITRK6	1.55e-03	90	103	4	SM00082
Domain	VWF_dom	FRAS1 ZAN JAG1	1.60e-03	42	103	3	IPR001007
Domain	C-type_lectin_CS	FCER2 MRC2 LY75	1.71e-03	43	103	3	IPR018378
Domain	TPR-like_helical_dom	NRDE2 TTC3 MTOR ZC3H7B KDM6A UTY	1.85e-03	233	103	6	IPR011990
Domain	-	EYS FAT1 NRXN3 SLIT1	1.89e-03	95	103	4	2.60.120.200
Domain	Ldl_recept_a	VLDLR LRP1B LRP1	1.95e-03	45	103	3	PF00057
Domain	-	STAB1 FCER2 MRC2 KLRB1	2.04e-03	97	103	4	3.10.100.10
Domain	SET	PRDM8 KMT5B PRDM16	2.08e-03	46	103	3	SM00317
Domain	-	VLDLR LRP1B LRP1	2.08e-03	46	103	3	4.10.400.10
Domain	LRRNT	CHAD LRRC70 LRRC52 SLIT1	2.12e-03	98	103	4	IPR000372
Domain	LRRNT	CHAD LRRC70 LRRC52 SLIT1	2.12e-03	98	103	4	SM00013
Domain	Znf_RING	UBR1 TTC3 RNF157 MIB1 NFXL1 RNF180 OBI1	2.19e-03	326	103	7	IPR001841
Domain	THDP-binding	PDHA1 OGDH	2.26e-03	13	103	2	IPR029061
Domain	-	PDHA1 OGDH	2.26e-03	13	103	2	3.40.50.970
Domain	LDLRA_1	VLDLR LRP1B LRP1	2.35e-03	48	103	3	PS01209
Domain	LDLRA_2	VLDLR LRP1B LRP1	2.50e-03	49	103	3	PS50068
Domain	LDrepeatLR_classA_rpt	VLDLR LRP1B LRP1	2.50e-03	49	103	3	IPR002172
Domain	LDLa	VLDLR LRP1B LRP1	2.50e-03	49	103	3	SM00192
Domain	LRR_8	CHAD LRRC70 LRRC52 SLIT1 SLITRK6	2.58e-03	171	103	5	PF13855
Pathway	REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES	CTSK CTSL CTSV	9.30e-06	8	79	3	M27796
Pathway	REACTOME_HDMS_DEMETHYLATE_HISTONES	KDM3A KDM3B KDM6A UTY	1.95e-05	29	79	4	MM14934
Pathway	REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR	CTSK CTSL CTSV	4.65e-05	13	79	3	MM14659
Pathway	REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR	CTSK CTSL CTSV	4.65e-05	13	79	3	M593
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	KDM3A KDM3B ELP1 KMT5B ELP2 PRDM16 KDM6A UTY	1.38e-04	272	79	8	M29619
Pathway	REACTOME_HDMS_DEMETHYLATE_HISTONES	KDM3A KDM3B KDM6A UTY	1.73e-04	50	79	4	M27232
Pathway	BIOCARTA_DICER_PATHWAY	AGO1 AGO4	3.07e-04	5	79	2	M22079
Pathway	REACTOME_CHROMATIN_MODIFYING_ENZYMES	KDM3A KDM3B KMT5B PRDM16 KDM6A UTY	4.41e-04	175	79	6	MM14941
Pathway	REACTOME_MICRORNA_MIRNA_BIOGENESIS	AGO1 AGO4	4.58e-04	6	79	2	MM14818
Pathway	REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS	AGO1 AGO4	4.58e-04	6	79	2	MM15083
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR	CFHR4 CFHR3	4.58e-04	6	79	2	M47880
Pathway	REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS	AGO1 AGO4	6.39e-04	7	79	2	M46421
Pathway	WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS	FAT1 JAG1 CTSL CTSV	7.42e-04	73	79	4	MM15906
Pathway	REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION	PRDM8 AGO1 AGO4	7.47e-04	32	79	3	M48012
Pathway	REACTOME_SIGNALING_BY_NOTCH2	FCER2 JAG1 MIB1	8.19e-04	33	79	3	M604
Pathway	REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS	AGO1 AGO4	8.49e-04	8	79	2	MM15082
Pathway	WP_THIAMINE_METABOLIC_PATHWAYS	PDHA1 OGDH	1.09e-03	9	79	2	M39774
Pathway	REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS	AGO1 AGO4	1.09e-03	9	79	2	M27340
Pathway	KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION	JAG1 MIB1	1.09e-03	9	79	2	M47866
Pathway	REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION	AGO1 AGO4	1.09e-03	9	79	2	M27810
Pathway	REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION	AGO1 AGO4	1.09e-03	9	79	2	M46436
Pathway	REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX	KDM3A AGO1 AGO4	1.15e-03	37	79	3	M29790
Pathway	REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES	CTSK CTSL CTSV	1.24e-03	38	79	3	MM14611
Pubmed	Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption.	CTSK CTSL CTSV	2.83e-08	3	107	3	19028686
Pubmed	An intracellular serpin regulates necrosis by inhibiting the induction and sequelae of lysosomal injury.	CTSK CTSL CTSV	2.83e-08	3	107	3	17889653
Pubmed	Sequential, but not Concurrent, Incubation of Cathepsin K and L with Type I Collagen Results in Extended Proteolysis.	CTSK CTSL CTSV	2.83e-08	3	107	3	30931961
Pubmed	Antifibrotic effects of curcumin are associated with overexpression of cathepsins K and L in bleomycin treated mice and human fibroblasts.	CTSK CTSL CTSV	2.83e-08	3	107	3	22126332
Pubmed	Normal development and fertility of knockout mice lacking the tumor suppressor gene LRP1b suggest functional compensation by LRP1.	VLDLR LRP1B SACS LRP1	8.28e-08	14	107	4	15082773
Pubmed	Cathepsin protease activity modulates amyloid load in extracerebral amyloidosis.	CTSK CTSL CTSV	1.13e-07	4	107	3	17068745
Pubmed	Lack of cathepsin activities alter or prevent the development of lung granulomas in a mouse model of sarcoidosis.	CTSK CTSL CTSV	1.13e-07	4	107	3	21251246
Pubmed	Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone.	CTSK CTSL CTSV	1.13e-07	4	107	3	16939398
Pubmed	Identification and characterization of a dense cluster of placenta-specific cysteine peptidase genes and related genes on mouse chromosome 13.	FANCC CTSL CTSV	2.82e-07	5	107	3	11829493
Pubmed	Thyroid functions of mouse cathepsins B, K, and L.	CTSK CTSL CTSV	2.82e-07	5	107	3	12782676
Pubmed	Cathepsin V, but not cathepsins L, B and K, may release angiostatin-like fragments from plasminogen.	CTSK CTSL CTSV	2.82e-07	5	107	3	18163891
Pubmed	Multiple sites on SARS-CoV-2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V.	CTSK CTSL CTSV	2.82e-07	5	107	3	33786919
Pubmed	Identification of Jmjd3 as an Essential Epigenetic Regulator of Hox Gene Temporal Collinear Activation for Body Axial Patterning in Mice.	KDM3A KDM3B KMT5B KDM6A UTY	4.29e-07	49	107	5	34368113
Pubmed	Mouse cathepsin M, a placenta-specific lysosomal cysteine protease related to cathepsins L and P.	CTSK CTSL CTSV	5.62e-07	6	107	3	10760593
Pubmed	UTX Affects Neural Stem Cell Proliferation and Differentiation through PTEN Signaling.	MTOR KDM6A UTY	9.82e-07	7	107	3	29551674
Pubmed	Lysosomal processing of progranulin.	CTSK CTSL CTSV	1.57e-06	8	107	3	28835281
Pubmed	Asparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activation.	CTSK CTSL CTSV	1.57e-06	8	107	3	22916010
Pubmed	Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome.	CFHR4 CFHR3 C4BPA	2.35e-06	9	107	3	20059470
Pubmed	Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations.	STT3B CTSL CTSV	3.34e-06	10	107	3	20541250
Pubmed	Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2alpha during inflammatory conditions.	CTSL CTSV	9.38e-06	2	107	2	19801522
Pubmed	Striking differences of LDL receptor-related protein 1B expression in mouse and human.	LRP1B LRP1	9.38e-06	2	107	2	15963947
Pubmed	Identification of procathepsin L (pCTS-L)-neutralizing monoclonal antibodies to treat potentially lethal sepsis.	CTSL CTSV	9.38e-06	2	107	2	36735789
Pubmed	Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury.	CTSL CTSV	9.38e-06	2	107	2	28332696
Pubmed	Impaired turnover of autophagolysosomes in cathepsin L deficiency.	CTSL CTSV	9.38e-06	2	107	2	20536383
Pubmed	Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice.	CTSL CTSV	9.38e-06	2	107	2	16636100
Pubmed	Cathepsin L Regulates Metabolic Networks Controlling Rapid Cell Growth and Proliferation.	CTSL CTSV	9.38e-06	2	107	2	31010818
Pubmed	The Importance of AGO 1 and 4 in Post-Transcriptional Gene Regulatory Function of tRF5-GluCTC, an Respiratory Syncytial Virus-Induced tRNA-Derived RNA Fragment.	AGO1 AGO4	9.38e-06	2	107	2	33233493
Pubmed	An H-YDb epitope is encoded by a novel mouse Y chromosome gene.	KDM6A UTY	9.38e-06	2	107	2	8944031
Pubmed	Diabetes-Induced Jagged1 Overexpression in Endothelial Cells Causes Retinal Capillary Regression in a Murine Model of Diabetes Mellitus: Insights Into Diabetic Retinopathy.	JAG1 MIB1	9.38e-06	2	107	2	27407072
Pubmed	Serum cathepsin levels in coronary artery ectasia.	CTSK CTSL	9.38e-06	2	107	2	20837372
Pubmed	A variant of pulmonary alveolar microlithiasis in nackt mice.	CTSL CTSV	9.38e-06	2	107	2	12014504
Pubmed	mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy.	MTOR CTSK	9.38e-06	2	107	2	37938323
Pubmed	Mice that express enzymatically inactive cathepsin L exhibit abnormal spermatogenesis.	CTSL CTSV	9.38e-06	2	107	2	12533435
Pubmed	Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance.	LRP1 LTF	9.38e-06	2	107	2	1464627
Pubmed	Cathepsin L was involved in vascular aging by mediating phenotypic transformation of vascular cells.	CTSL CTSV	9.38e-06	2	107	2	36206719
Pubmed	Sequence and expression of the cDNA for MEP (major excreted protein), a transformation-regulated secreted cathepsin.	CTSL CTSV	9.38e-06	2	107	2	3689328
Pubmed	Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease.	CTSL CTSV	9.38e-06	2	107	2	17671649
Pubmed	The alpha -chains of C4b-binding protein mediate complex formation with low density lipoprotein receptor-related protein.	LRP1 C4BPA	9.38e-06	2	107	2	11705989
Pubmed	Contribution of cathepsin L to secretome composition and cleavage pattern of mouse embryonic fibroblasts.	CTSL CTSV	9.38e-06	2	107	2	21972973
Pubmed	Cathepsin L stabilizes the histone modification landscape on the Y chromosome and pericentromeric heterochromatin.	CTSL CTSV	9.38e-06	2	107	2	16705169
Pubmed	Complete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. An abundant transcript induced by transformation of fibroblasts.	CTSL CTSV	9.38e-06	2	107	2	2835398
Pubmed	The lysosomal cysteine protease cathepsin L regulates keratinocyte proliferation by control of growth factor recycling.	CTSL CTSV	9.38e-06	2	107	2	16079282
Pubmed	Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation.	CTSL CTSV	9.38e-06	2	107	2	18957203
Pubmed	Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus.	CTSL CTSV	9.38e-06	2	107	2	9545226
Pubmed	Cathepsin L gene expression and promoter activation in rodent granulosa cells.	CTSL CTSV	9.38e-06	2	107	2	14563703
Pubmed	Cathepsin L inhibition prevents murine autoimmune diabetes via suppression of CD8(+) T cell activity.	CTSL CTSV	9.38e-06	2	107	2	20877570
Pubmed	Cathepsin L inactivates human trypsinogen, whereas cathepsin L-deletion reduces the severity of pancreatitis in mice.	CTSL CTSV	9.38e-06	2	107	2	19900452
Pubmed	Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway.	DAPK1 MTOR	9.38e-06	2	107	2	27930338
Pubmed	Thymocyte expression of cathepsin L is essential for NKT cell development.	CTSL CTSV	9.38e-06	2	107	2	12368909
Pubmed	Cloning and characterization of a mouse cysteine proteinase.	CTSL CTSV	9.38e-06	2	107	2	3533924
Pubmed	Surface activation of pro-cathepsin L.	CTSL CTSV	9.38e-06	2	107	2	1482371
Pubmed	Impaired hair follicle morphogenesis and cycling with abnormal epidermal differentiation in nackt mice, a cathepsin L-deficient mutation.	CTSL CTSV	9.38e-06	2	107	2	12163394
Pubmed	Expression of human cathepsin L or human cathepsin V in mouse thymus mediates positive selection of T helper cells in cathepsin L knock-out mice.	CTSL CTSV	9.38e-06	2	107	2	20347002
Pubmed	Cathepsin L-deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy.	CTSL CTSV	9.38e-06	2	107	2	15154914
Pubmed	Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway.	IGFBP2 MTOR	9.38e-06	2	107	2	17289850
Pubmed	Evolution of placentally expressed cathepsins.	CTSL CTSV	9.38e-06	2	107	2	12054558
Pubmed	Cathepsin L is involved in proliferation and invasion of breast cancer cells.	CTSL CTSV	9.38e-06	2	107	2	26639231
Pubmed	An alternate targeting pathway for procathepsin L in mouse fibroblasts.	CTSL CTSV	9.38e-06	2	107	2	11929604
Pubmed	Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis.	CTSL CTSV	9.38e-06	2	107	2	20023699
Pubmed	Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells.	MTOR ROS1	9.38e-06	2	107	2	31053160
Pubmed	Cathepsins in Rotator Cuff Tendinopathy: Identification in Human Chronic Tears and Temporal Induction in a Rat Model.	CTSK CTSL	9.38e-06	2	107	2	25558848
Pubmed	Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels.	CTSL CTSV	9.38e-06	2	107	2	18469859
Pubmed	Streptococcus pneumoniae Interacts with pIgR expressed by the brain microvascular endothelium but does not co-localize with PAF receptor.	PTAFR PIGR	9.38e-06	2	107	2	24841255
Pubmed	Pro-atherogenic shear stress and HIV proteins synergistically upregulate cathepsin K in endothelial cells.	CTSK CTSV	9.38e-06	2	107	2	24719048
Pubmed	Cathepsin L plays an active role in involution of the mouse mammary gland.	CTSL CTSV	9.38e-06	2	107	2	12815617
Pubmed	Response to comment on "Cathepsin-L influences the expression of extracellular matrix in lymphoid organs and plays a role in the regulation of thymic output and of peripheral T cell number".	CTSL CTSV	9.38e-06	2	107	2	16621972
Pubmed	Cathepsin L regulates pathogenicCD4 T cells in experimental autoimmune encephalomyelitis.	CTSL CTSV	9.38e-06	2	107	2	33540247
Pubmed	The protease cathepsin L regulates Th17 cell differentiation.	CTSL CTSV	9.38e-06	2	107	2	26343333
Pubmed	Increased nucleolar localization of SpiA3G in classically but not alternatively activated macrophages.	CTSL CTSV	9.38e-06	2	107	2	20338168
Pubmed	Cathepsin L coexists with Cytotoxic T-lymphocyte Antigen-2 alpha in distinct regions of the mouse brain.	CTSL CTSV	9.38e-06	2	107	2	27586811
Pubmed	Autophagy and cathepsin L are involved in the antinociceptive effect of DMBC in a mouse acetic acid-writhing model.	CTSL CTSV	9.38e-06	2	107	2	23912553
Pubmed	Cathepsin L Helps to Defend Mice from Infection with Influenza A.	CTSL CTSV	9.38e-06	2	107	2	27716790
Pubmed	The radiation-induced nackt (nkt) allele is a loss-of-function mutation of the mouse cathepsin L gene.	CTSL CTSV	9.38e-06	2	107	2	16393949
Pubmed	Cathepsin L in bone marrow-derived cells is required for retinal and choroidal neovascularization.	CTSL CTSV	9.38e-06	2	107	2	20304958
Pubmed	Characterization and comparative mapping of the porcine CTSL gene indicates a novel synteny between HSA9q21-->q22 and SSC10q11-->q12.	CTSL CTSV	9.38e-06	2	107	2	11978977
Pubmed	Comparison of cathepsin L synthesized by normal and transformed cells at the gene, message, protein, and oligosaccharide levels.	CTSL CTSV	9.38e-06	2	107	2	2275556
Pubmed	The CD4 T cell-deficient mouse mutation nackt (nkt) involves a deletion in the cathepsin L (CtsI) gene.	CTSL CTSV	9.38e-06	2	107	2	11398968
Pubmed	Protein S-glutathionylation alters superoxide/hydrogen peroxide emission from pyruvate dehydrogenase complex.	PDHA1 OGDH	9.38e-06	2	107	2	28242228
Pubmed	Sex-specific differences in expression of histone demethylases Utx and Uty in mouse brain and neurons.	KDM6A UTY	9.38e-06	2	107	2	18434530
Pubmed	Cathepsin L protects mice from mycoplasmal infection and is essential for airway lymphangiogenesis.	CTSL CTSV	9.38e-06	2	107	2	23600672
Pubmed	Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth: a study with cathepsin-L-deficient mice.	CTSL CTSV	9.38e-06	2	107	2	12466121
Pubmed	Clearance of Neutrophils From ICH-Affected Brain by Macrophages Is Beneficial and Is Assisted by Lactoferrin and CD91.	LRP1 LTF	9.38e-06	2	107	2	38063014
Pubmed	Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly.	CTSL CTSV	9.38e-06	2	107	2	10516062
Pubmed	Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.	CTSL CTSV	9.38e-06	2	107	2	19096818
Pubmed	Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling.	CTSL CTSV	9.38e-06	2	107	2	11023992
Pubmed	Close relationship of the major excreted protein of transformed murine fibroblasts to thiol-dependent cathepsins.	CTSL CTSV	9.38e-06	2	107	2	3755373
Pubmed	[Effect of bushen tiaojing recipe and xiaoyao pill on expression of cathepsin-L mRNA in gonadotropin-primed mice].	CTSL CTSV	9.38e-06	2	107	2	21434350
Pubmed	Target sequencing and CRISPR/Cas editing reveal simultaneous loss of UTX and UTY in urothelial bladder cancer.	KDM6A UTY	9.38e-06	2	107	2	27533081
Pubmed	Cell type-specific functions of the lysosomal protease cathepsin L in the heart.	CTSL CTSV	9.38e-06	2	107	2	17942402
Pubmed	The human cysteine protease cathepsin V can compensate for murine cathepsin L in mouse epidermis and hair follicles.	CTSL CTSV	9.38e-06	2	107	2	15679121
Pubmed	Identification on melanoma cells of p39, a cysteine proteinase that cleaves C3, the third component of complement: amino-acid-sequence identities with procathepsin L.	CTSL CTSV	9.38e-06	2	107	2	8554545
Pubmed	Cathepsin L plays a major role in cholecystokinin production in mouse brain cortex and in pituitary AtT-20 cells: protease gene knockout and inhibitor studies.	CTSL CTSV	9.38e-06	2	107	2	19589362
Pubmed	Cathepsin L is essential for onset of autoimmune diabetes in NOD mice.	CTSL CTSV	9.38e-06	2	107	2	16184198
Pubmed	Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice.	CTSL CTSV	9.38e-06	2	107	2	21868704
Pubmed	Cathepsin-L contributes to cardiac repair and remodelling post-infarction.	CTSL CTSV	9.38e-06	2	107	2	21147810
Pubmed	Identification of a membrane-associated cysteine protease with possible dual roles in the endoplasmic reticulum and protein storage vacuole.	CTSL CTSV	9.38e-06	2	107	2	11022031
Pubmed	B-cell lymphopoiesis is regulated by cathepsin L.	CTSL CTSV	9.38e-06	2	107	2	23585893
Pubmed	Positive and negative selection on mammalian Y chromosomes.	KDM6A UTY	9.38e-06	2	107	2	15758204
Pubmed	Lysine demethylases KDM6A and UTY: The X and Y of histone demethylation.	KDM6A UTY	9.38e-06	2	107	2	31097364
Pubmed	Cathepsin L is crucial for the development of early experimental diabetic nephropathy.	CTSL CTSV	9.38e-06	2	107	2	27575559
Cytoband	1q32	CFHR4 CFHR3 C4BPA	2.10e-04	49	107	3	1q32
GeneFamily	Cathepsins	CTSK CTSL CTSV CTSW	3.23e-07	15	73	4	470
GeneFamily	PHD finger proteins\|Lysine demethylases	KDM3A KDM3B KDM6A UTY	2.44e-06	24	73	4	485
GeneFamily	Low density lipoprotein receptors	VLDLR LRP1B LRP1	1.75e-05	13	73	3	634
GeneFamily	C-type lectin domain family	FCER2 MRC2 LY75 KLRB1	3.83e-05	47	73	4	494
GeneFamily	Elongator acetyltransferase complex	ELP1 ELP2	2.39e-04	6	73	2	539
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	PRDM8 KMT5B PRDM16	3.45e-04	34	73	3	487
GeneFamily	Zinc fingers CCCH-type	ZC3H11B ZC3H11A ZC3H7B	3.77e-04	35	73	3	73
GeneFamily	Complement system\|Sushi domain containing	CFHR4 CFHR3 C3AR1	4.10e-04	36	73	3	492
GeneFamily	Argonaute/PIWI family	AGO1 AGO4	4.43e-04	8	73	2	408
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	TNFRSF4 FCER2 MRC2 JAG1 LRP1 LY75 KLRB1	1.05e-03	394	73	7	471
GeneFamily	Endogenous ligands\|Minor histocompatibility antigens	APOBEC3B LY75 UTY	1.14e-03	51	73	3	870
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TTC3 ZC3H7B KDM6A UTY	1.21e-03	115	73	4	769
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CFHR4 CFHR3 C4BPA	1.58e-03	57	73	3	1179
GeneFamily	Zinc fingers C2H2-type\|PR/SET domain family	PRDM8 PRDM16	2.10e-03	17	73	2	1197
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	STAB1 LY75	5.29e-03	27	73	2	1253
Coexpression	ROSS_AML_WITH_PML_RARA_FUSION	TNFRSF4 STAB1 IGFBP2 MRC2 JAG1 CTSW	9.45e-07	80	107	6	M15368
Coexpression	GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP	TYW3 EMB CFHR4 STAB1 FCER2 SPHKAP NFXL1	1.80e-05	199	107	7	M6131
Coexpression	GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_UP	PTAFR TNFRSF4 STAB1 FCER2 C3AR1 CTSV UTY	1.86e-05	200	107	7	M5100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305	ZNF560 TTC3 RNF157 JAG1 MYOM2 SLITRK6 CTSK UTY	3.76e-05	266	100	8	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X
CoexpressionAtlas	Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3	PTAFR LRP1 C3AR1 CTSK CTSL	4.04e-05	81	100	5	GSM605865_100
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 ZAN LRP1B TNFRSF4 NRXN3 IGFBP2 LTF	1.77e-07	169	107	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	Control-Classical_Monocyte\|Control / Disease condition and Cell class	SGMS2 EMB PTAFR GASK1B TMEM91 STAB1 LRP1	4.50e-07	194	107	7	9e33e1b54b4114f9e6981819834bb796ed7192b5
ToppCell	mLN-(4)_Monocyte\|mLN / shred on region, Cell_type, and subtype	SGMS2 DAPK1 GASK1B STAB1 MTMR11 LRP1 C3AR1	5.35e-07	199	107	7	6795ff31f92580195c9db776951f99d647484d24
ToppCell	mLN-Monocyte\|mLN / Region, Cell class and subclass	SGMS2 DAPK1 GASK1B STAB1 MTMR11 LRP1 C3AR1	5.35e-07	199	107	7	241f790cd5d8a9b2451333deecc826a673bae70a
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SGMS2 PTAFR GASK1B STAB1 LRP1 C3AR1 CTSL	5.35e-07	199	107	7	0f3ce61bbae69f7e333ed8dacf7257645624e163
ToppCell	mLN-Monocyte-Monocyte\|mLN / Region, Cell class and subclass	SGMS2 DAPK1 GASK1B STAB1 MTMR11 LRP1 C3AR1	5.35e-07	199	107	7	dcee372774c169a3048bdaed3734b3215bf8ffad
ToppCell	mLN-(4)_Monocyte-(40)_Monocyte\|mLN / shred on region, Cell_type, and subtype	SGMS2 DAPK1 GASK1B STAB1 MTMR11 LRP1 C3AR1	5.35e-07	199	107	7	bcbb1eee8d79bf670dbe113094c3a292b135ce2f
ToppCell	Sigmoid-Macrophage\|Sigmoid / Region, Cell class and subclass	DAPK1 PTAFR GASK1B STAB1 LRP1 C3AR1 CTSL	5.53e-07	200	107	7	b07ac0ff3b8530e99094678fed80f35949cafac8
ToppCell	Sigmoid-(6)_Macrophage\|Sigmoid / shred on region, Cell_type, and subtype	DAPK1 PTAFR GASK1B STAB1 LRP1 C3AR1 CTSL	5.53e-07	200	107	7	9e10cca4429de2c4c8c3c6cf2c9e28637a095be9
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GLYATL2 CHAD RAD51AP2 NRXN3 PIGR LTF	3.39e-06	169	107	6	db73dae011ff3749b3706e50ab46d03b775dd6bb
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GLYATL2 CHAD RAD51AP2 NRXN3 PIGR LTF	3.39e-06	169	107	6	97b7047b87ce0052d8580565c9b44fd2aa6f0d5c
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GLYATL2 CHAD RAD51AP2 NRXN3 PIGR LTF	3.39e-06	169	107	6	1a684471dbda42e1470e5a889648666e14f25982
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	DAPK1 APOBEC3B GASK1B STAB1 LRP1 C3AR1	3.51e-06	170	107	6	9ac1ef57f14418a5dd2aa16861c3df698c28f5ed
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DIPK2A STAB1 FCER2 LRP1 NFXL1 C3AR1	3.63e-06	171	107	6	5e93c76ee60f9d0590ebb140812653a5e1369417
ToppCell	10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages\|bone_marrow / Manually curated celltypes from each tissue	SGMS2 DAPK1 GASK1B STAB1 LRP1 CTSL	4.01e-06	174	107	6	0746344d62aa7ab77c378e9d5a9f9238e741a76b
ToppCell	COPD-Lymphoid-ILC_A\|COPD / Disease state, Lineage and Cell class	EMB JAG1 PLCL2 VAV3 KLRB1 CTSW	4.29e-06	176	107	6	484452cb38fe4604f0910a068361ed461b5b0c21
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 ZAN LRP1B FAT1 ROS1 MYOM2	5.53e-06	184	107	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 ZAN LRP1B FAT1 ROS1 MYOM2	5.53e-06	184	107	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 ZAN LRP1B FAT1 ROS1 MYOM2	5.53e-06	184	107	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Control-Lymphoid-ILC_A\|Lymphoid / Disease state, Lineage and Cell class	IGFBP2 JAG1 PLCL2 VAV3 KLRB1 CTSW	5.71e-06	185	107	6	520795866d44def5be3910ce8e728045c716a24d
ToppCell	Control-T_cells-NK_cells\|Control / group, cell type (main and fine annotations)	EMB PLCL2 VAV3 MYOM2 KLRB1 CTSW	5.71e-06	185	107	6	755c0998c729f462399f1d5e88adf4bfae31be30
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LRP1B GASK1B STAB1 LRP1 NFXL1 PRDM16	5.89e-06	186	107	6	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	COVID-19-T_cells-NK_cells\|COVID-19 / group, cell type (main and fine annotations)	EMB PLCL2 VAV3 MYOM2 KLRB1 CTSW	6.45e-06	189	107	6	b699152dfbb8cd8ed724e1e5a51838f29b681b62
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EMB PLCL2 VAV3 MYOM2 KLRB1 CTSW	6.85e-06	191	107	6	9b8b64a36e27a2523b8730c7922fd7ad865a021e
ToppCell	Mesenchymal_cells-Ng2+_MSCs\|World / Lineage and Cell class	VLDLR SGMS2 FAT1 MRC2 SLITRK6 CTSK	7.06e-06	192	107	6	0703b8ec6960ff975ee5a2737054db67cab016b5
ToppCell	background-NK_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	EMB PLCL2 VAV3 MYOM2 KLRB1 CTSW	7.27e-06	193	107	6	f8d6eff1e04926f85d265ec39fe66897fe29574d
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	EMB PLCL2 VAV3 MYOM2 KLRB1 CTSW	7.27e-06	193	107	6	1cb666375bc4e1b11a146d20896c9b5ae6fd0887
ToppCell	(1)_Osterolineage_cells\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	VLDLR SGMS2 FAT1 MRC2 SLITRK6 CTSK	7.27e-06	193	107	6	035eeea9f77c4bf9cd85f07fa791b6c857be76b5
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SGMS2 DAPK1 STAB1 LRP1 C3AR1 CTSL	7.27e-06	193	107	6	00c9c2945d2bdaa128e054cf3c59df86a279b659
ToppCell	Mild-NK\|Mild / Disease group and Cell class	TNFRSF4 JAG1 VAV3 MYOM2 KLRB1 CTSW	7.71e-06	195	107	6	be88a7507cd6a0a9dfe424312d9365039eef7b74
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SGMS2 PTAFR GASK1B STAB1 LRP1 C3AR1	7.71e-06	195	107	6	403d874198a7bde626b0d0b4efad8dbb34060761
ToppCell	COVID-19-lung-NK/NKT\|lung / Disease (COVID-19 only), tissue and cell type	EMB PLCL2 VAV3 MYOM2 KLRB1 CTSW	7.71e-06	195	107	6	3ab941a369e3815f338890b116dc77aefa054098
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRAS1 DAPK1 GPR160 FAT1 VAV3 PRDM16	7.94e-06	196	107	6	c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCell	(7)_Monocyte\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	PTAFR GASK1B STAB1 MTMR11 LRP1 C3AR1	7.94e-06	196	107	6	0232167559dcd2d86ee8b78017cf5f2a084b2cb7
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_3\|COVID-19_Mild / Disease condition and Cell class	EMB PTAFR GASK1B STAB1 ZC3H11A LRP1	7.94e-06	196	107	6	f245e929a286cb097130572e1027b4f01be8b04d
ToppCell	(6)_Macrophage\|World / shred on Cell_type and subtype	DAPK1 PTAFR GASK1B STAB1 LRP1 CTSL	8.17e-06	197	107	6	010b275d4da4a896175ad7fbaa96d1dc11a0b744
ToppCell	NS-moderate-d_07-13-Myeloid-Non-resident_Macrophage\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PTAFR GASK1B STAB1 LRP1 C3AR1 CTSL	8.17e-06	197	107	6	774a5053f43ac7d614c127ae7363d32a3a194f63
ToppCell	(7)_MNP\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	PTAFR GASK1B STAB1 LRP1 C3AR1 CTSL	8.17e-06	197	107	6	6790346736946984cc80d67668523ba70ab0b380
ToppCell	10x5'-lymph-node_spleen-Myeloid_Monocytic\|lymph-node_spleen / Manually curated celltypes from each tissue	PTAFR GASK1B STAB1 MTMR11 LRP1 C3AR1	8.41e-06	198	107	6	2541f1095ed91e6789cb888cf39a208b8107726a
ToppCell	VE-mono1-\|VE / Condition, Cell_class and T cell subcluster	PTAFR APOBEC3B STAB1 LRP1 C3AR1 CTSL	8.41e-06	198	107	6	2959d6e4992c36040ec9637f5a2daed02b35cf30
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	DAPK1 GASK1B STAB1 LRP1 C3AR1 CTSL	8.41e-06	198	107	6	579a22199643440b98e381147779ced630d4ed66
ToppCell	VE-mono1\|VE / Condition, Cell_class and T cell subcluster	PTAFR APOBEC3B STAB1 LRP1 C3AR1 CTSL	8.41e-06	198	107	6	c742871b8ec4720b1848991551c7c1f4000ebd85
ToppCell	Monocytes-Phagocytic_CD16+_macrophages\|World / Immune cells in Kidney/Urine in Lupus Nephritis	PTAFR GASK1B STAB1 LRP1 C3AR1 CTSL	8.41e-06	198	107	6	09009cc966bf1503c3b15dfa079a6c5f6ad1f507
ToppCell	10x5'-lymph-node_spleen-Myeloid_Monocytic-Classical_monocytes\|lymph-node_spleen / Manually curated celltypes from each tissue	PTAFR GASK1B STAB1 MTMR11 LRP1 C3AR1	8.41e-06	198	107	6	934dacb67d71faa2f8732c39d7f8e64b0ee75396
ToppCell	Monocytes\|World / Immune cells in Kidney/Urine in Lupus Nephritis	PTAFR GASK1B STAB1 LRP1 C3AR1 CTSL	8.41e-06	198	107	6	8beccf03c9ec9cd02a96107a9d7ca9a6764c6a61
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	DAPK1 GASK1B STAB1 LRP1 C3AR1 CTSL	8.66e-06	199	107	6	c4fc638a8dad3a9b77634e8912a9326c8a2f11f5
ToppCell	10x5'-bone_marrow-Myeloid_Monocytic\|bone_marrow / Manually curated celltypes from each tissue	PTAFR GASK1B STAB1 LRP1 C3AR1 CTSL	8.66e-06	199	107	6	62b0861faf173eead75678aad10d396cd0d80c2c
ToppCell	PBMC-Control-cDC_0\|Control / Compartment, Disease Groups and Clusters	PTAFR GASK1B STAB1 MTMR11 AGO1 LRP1	8.66e-06	199	107	6	ebf03979ef56e978d72db475bb635b43b9cbe402
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DAPK1 GASK1B LRP1 C3AR1 CTSK CTSL	8.66e-06	199	107	6	80ed217d28ba1c07facd0e103c25a02658dd848d
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	DAPK1 GASK1B STAB1 LRP1 C3AR1 CTSL	8.66e-06	199	107	6	697a9a58c0cdb77222700d029873355d37f6ab28
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	DAPK1 GASK1B STAB1 LRP1 C3AR1 CTSL	8.66e-06	199	107	6	6783d571d28eac891fcc70380f176b53f35c88ba
ToppCell	Sigmoid-Macrophage-Macrophage\|Sigmoid / Region, Cell class and subclass	DAPK1 PTAFR GASK1B STAB1 LRP1 CTSL	8.91e-06	200	107	6	9ee3a799de7bade1bfe94b6827461633f02bc1dc
ToppCell	Sigmoid-(6)_Macrophage-(61)_LYVE1_Macrophage\|Sigmoid / shred on region, Cell_type, and subtype	PTAFR GASK1B STAB1 LRP1 C3AR1 CTSL	8.91e-06	200	107	6	bc0280d52e4edc2c5edf4ead164a1c7cf3fccd60
ToppCell	Sigmoid-(6)_Macrophage-(60)_Macrophage\|Sigmoid / shred on region, Cell_type, and subtype	DAPK1 PTAFR GASK1B STAB1 LRP1 CTSL	8.91e-06	200	107	6	ad84a83a5a1893f7b053d39eddeca851463a8ff0
ToppCell	Sigmoid-Macrophage-LYVE1_Macrophage\|Sigmoid / Region, Cell class and subclass	PTAFR GASK1B STAB1 LRP1 C3AR1 CTSL	8.91e-06	200	107	6	851a1b372ddbec522829069e69ed36a1f4832131
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FRAS1 EMB RNF157 NRXN3 IGFBP2 SLITRK6	8.91e-06	200	107	6	de55100e98d3e9b8a74e37aebcd3afa2b0996527
ToppCell	severe-CD163+_Monocytes_(Sample_ID1_d7)\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PTAFR GASK1B STAB1 IGFBP2 LRP1 C3AR1	8.91e-06	200	107	6	a3f22826f3d8f917ff0594bdadd93b60763bcaa2
ToppCell	(61)_LYVE1_Macrophage\|World / shred on Cell_type and subtype	PTAFR GASK1B STAB1 LRP1 C3AR1 CTSL	1.05e-05	206	107	6	711e961a9a03bfd2f0958bd14f25f7f207a2f2b5
ToppCell	droplet-Pancreas-Exocrine-18m-Hematologic-leukocyte\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTAFR STAB1 C3AR1 VAV3 RNF180	2.40e-05	142	107	5	bf4a9633d128805a0d7e426d6fe6c29db1ff8c81
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175\|Adult / Lineage, Cell type, age group and donor	FAT1 STS ROS1 C4BPA LTF	3.12e-05	150	107	5	b0b6ba3686d3eb8a9b249d30be14111de3b893be
ToppCell	PBMC-Control-cDC_2\|Control / Compartment, Disease Groups and Clusters	CHAD TNFRSF4 FAT1 NRXN3 KLRB1	3.42e-05	153	107	5	4ee37266b0054f276c7a73ab9220f681b9d74c71
ToppCell	droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRAG1 FANCC TBC1D32 UTY TOP3A	3.99e-05	158	107	5	1d78578dc1f8ba43dacdccae1082c0b9d749f64d
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTAFR PGAP6 GPR160 STAB1 C3AR1	4.50e-05	162	107	5	ec29c6f1c31e41ddcb041a49c593910edaf0532c
ToppCell	5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GLYATL2 LRP1B PIGR LTF CTSV	4.63e-05	163	107	5	a1fbefe53523a9879a4d4b493071059798b5f917
ToppCell	5'-Airway_Nasal_SMG-Epithelial\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GLYATL2 LRP1B PIGR LTF CTSV	4.63e-05	163	107	5	454a5e87e2f9f66e38cc5aa1b433c47b54c9be42
ToppCell	5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GLYATL2 LRP1B PIGR LTF CTSV	4.63e-05	163	107	5	d9bd9d90cfa4e85d5ea51f8f3ee14a700571f508
ToppCell	5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GLYATL2 LRP1B PIGR LTF CTSV	4.63e-05	163	107	5	f6847f47a8856c0d4136c1af317432d45eccfde9
ToppCell	5'-Airway_Nasal_SMG\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GLYATL2 LRP1B PIGR LTF CTSV	4.63e-05	163	107	5	d8450bf9c6d2ec5dd1472952c9e65f82f995337a
ToppCell	5'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GLYATL2 LRP1B PIGR LTF CTSV	4.63e-05	163	107	5	be6cc44df9a2b10dce1a353717c279c3558f8fec
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF560 ZC3H11B PRAG1 IGFBP2 SMCR5	4.77e-05	164	107	5	d167c7a987b9b35d1e7725c803df4f9cd5380e47
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	UBR1 GASK1B MTMR11 JAG1 WDFY1	4.91e-05	165	107	5	62457b7b74c6eae42d91d65e7dc6df6bf8e061f7
ToppCell	mild-Myeloid-CD14_Monocytes_3\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	GASK1B STAB1 LRP1 C3AR1 CTSL	4.91e-05	165	107	5	a6547bb2c9c40b4878325da19b9def0ef644fa25
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGMS2 PIGR NFXL1 LTF SLITRK6	5.05e-05	166	107	5	60060b03f2abfa3cc08107ab5a9f578e60e4ae16
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGMS2 PIGR NFXL1 LTF SLITRK6	5.05e-05	166	107	5	ec9161d388db5a257b8d125c14f9dd911d5d5d4a
ToppCell	10x5'-blood-Lymphocytic_NK-NK_CD56bright_CD16-\|blood / Manually curated celltypes from each tissue	FRAS1 FAM217A JAG1 KLRB1 CTSW	5.05e-05	166	107	5	ba42349a68b22e91a0340bda1ccecd6c7592392f
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SGMS2 PIGR NFXL1 LTF SLITRK6	5.05e-05	166	107	5	4586d6725403f879fc96f67be579022587ce1906
ToppCell	(0)_Myeloid-(00)_Monocyte-(000)_CD14+_Monocyte\|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization)	PTAFR GASK1B TMEM91 STAB1 LRP1	5.20e-05	167	107	5	7d9fd6a7a45c2aa0d5f2e3960ca4c97ee8836ba5
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTAFR PGAP6 GPR160 STAB1 C3AR1	5.81e-05	171	107	5	bf475a69db04d4a886e442704955c6a96ff0de46
ToppCell	Bronchial_Biopsy-Immune-Mast_cells\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	DAPK1 TNFRSF4 STAB1 C3AR1 CTSW	5.98e-05	172	107	5	c477008444d2d71071177807870d7455e90c2fad
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FRAS1 ADGRB1 RNF157 NRXN3 SLITRK6	5.98e-05	172	107	5	bc3ed05fdd94d5e1f19285aea867b1453292baec
ToppCell	COPD-Lymphoid-ILC_A\|Lymphoid / Disease state, Lineage and Cell class	JAG1 PLCL2 VAV3 KLRB1 CTSW	6.14e-05	173	107	5	4a0043b29f8ede5a74bdb38cbf2c70e12b25e130
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|lymph-node_spleen / Manually curated celltypes from each tissue	SGMS2 PTAFR GASK1B STAB1 LRP1	6.14e-05	173	107	5	783b8fa08b9d8f597f251793eae164151662f1f9
ToppCell	Int-URO-Lymphocyte-T_NK-NK_CD56bright\|Int-URO / Disease, Lineage and Cell Type	TNFRSF4 TBC1D32 PRDM16 KLRB1 CTSW	6.31e-05	174	107	5	93c7acd5941a5f235ec4c57461f78ee2871e7336
ToppCell	COPD-Lymphoid-ILC_A\|World / Disease state, Lineage and Cell class	EMB PLCL2 VAV3 KLRB1 CTSW	6.49e-05	175	107	5	e773e330de36f8a0aa9398a176ed7edb5599c582
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VLDLR ZNF106 KMT5B VAV3 KDM6A	6.66e-05	176	107	5	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTAFR GPR160 STAB1 NFXL1 C3AR1	6.66e-05	176	107	5	adb679e69c0c17f0caee4c141bac55d03c963012
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PRAG1 PRDM8 SPHKAP ROS1 VAV3	6.66e-05	176	107	5	40993c41c1017b53039a337174fc56632b278609
ToppCell	Control-Lymphoid-ILC_B\|World / Disease state, Lineage and Cell class	TNFRSF4 JAG1 PLCL2 KLRB1 CTSW	6.66e-05	176	107	5	57ad9c9f5fda6bc24695587ed14190514fd8d96a
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTAFR GPR160 STAB1 NFXL1 C3AR1	6.84e-05	177	107	5	ab92ffc9624850a50c88e6b8f3a517ff2251ff15
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILC2\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRDM8 STS C3AR1 KLRB1 CTSW	6.84e-05	177	107	5	9828504591599619649d41a78daf7c052729c669
ToppCell	Control-Lymphoid-ILC_B\|Control / Disease state, Lineage and Cell class	TNFRSF4 JAG1 PLCL2 KLRB1 CTSW	6.84e-05	177	107	5	3d0f4b4054185ba77071efbe53df34fee84b9b24
ToppCell	(5)_Glands_mucous\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	GLYATL2 CHAD PIGR C4BPA SLITRK6	7.03e-05	178	107	5	f0f19b0d78f2cc5df4d4c321a953a6e447d5114a
ToppCell	10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	FRAS1 SGMS2 FAT1 MRC2 RNF180	7.03e-05	178	107	5	e32f5ed7a492edfa7073416008b1fcfae6b854ad
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FRAS1 DAPK1 NRXN3 ROS1 PRDM16	7.22e-05	179	107	5	815b959ce8721c5ded70c0ca6e318dafc691746e
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RAD51AP2 NRXN3 PIGR C4BPA PRDM16	7.22e-05	179	107	5	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	Somatosensory_Cortex_(S1)\|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DAPK1 PRAG1 ROS1 VAV3 UTY	7.22e-05	179	107	5	82348bf56a4525b2f485696cab5b2ea6e96c2f91
ToppCell	(5)_Epithelial_cells-(5)_Glands_mucous\|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	GLYATL2 CHAD GASK1B PIGR C4BPA	7.41e-05	180	107	5	a4118adaf4b09e2ca01b662ed60e7bbf32a24d58
ToppCell	lymphoid-NK_cell-TNFRSF18+IL7R+_NK_cell\|World / Lineage, cell class and subclass	TNFRSF4 MYOM2 PRDM16 KLRB1 CTSW	7.61e-05	181	107	5	0d096d7d557fd2e71b35e41816e11d7e83cd9210
ToppCell	wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILCP\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CHAD TNFRSF4 EYS JAG1 KLRB1	7.81e-05	182	107	5	6bd48c5d60a259719f65cacee4b8135247e78fa9
ToppCell	IPF-Lymphoid-ILC_A\|World / Disease state, Lineage and Cell class	EMB PLCL2 VAV3 KLRB1 CTSW	7.81e-05	182	107	5	f91bb45baaec76cb3bb26eedbcf0709b2492e93f
Drug	Z-Phe-Phe-CHN2	STS CTSL CTSV CTSW	4.39e-06	24	106	4	CID005486921
Drug	Ab-Z	CYP1A2 CTSK CTSL CTSV TOP3A	6.29e-06	56	106	5	CID000448533
Drug	chloroquine	CYP1A2 EMB STS LRP1 C3AR1 CTSK CTSL CTSV CTSW	8.23e-06	288	106	9	CID000002719
Drug	cimaterol	CTSK CTSL CTSV CTSW	9.64e-06	29	106	4	CID000002755
Drug	E64A	CTSK CTSL CTSV CTSW	1.27e-05	31	106	4	CID000173548
Drug	C01631	CTSK CTSL CTSV CTSW	1.27e-05	31	106	4	CID000439539
Drug	desmedipham	CTSK CTSL CTSV CTSW	1.27e-05	31	106	4	CID000024743
Drug	Compound-1	FANCC JAG1 CTSK CTSL CTSV CTSW	2.00e-05	119	106	6	CID006324619
Drug	3-Amino-5-Phenylpentane	CTSK CTSV	2.15e-05	2	106	2	DB02869
Disease	Neoplasm of uncertain or unknown behavior of bladder	FANCC MTOR KDM6A	1.82e-05	15	103	3	C0496930
Disease	Benign neoplasm of bladder	FANCC MTOR KDM6A	1.82e-05	15	103	3	C0154017
Disease	Carcinoma in situ of bladder	FANCC MTOR KDM6A	1.82e-05	15	103	3	C0154091
Disease	Malignant neoplasm of salivary gland	DAPK1 FAT1 IGFBP2 JAG1	1.87e-05	45	103	4	C0220636
Disease	Salivary Gland Neoplasms	DAPK1 FAT1 IGFBP2 JAG1	2.23e-05	47	103	4	C0036095
Disease	otitis media (biomarker_via_orthology)	CTSK CTSL CTSV	2.71e-05	17	103	3	DOID:10754 (biomarker_via_orthology)
Disease	Adenoid Cystic Carcinoma	DAPK1 FAT1 IGFBP2 JAG1 KDM6A	2.72e-05	100	103	5	C0010606
Disease	Carcinoma of bladder	FANCC MTOR KDM6A	3.24e-05	18	103	3	C0699885
Disease	Kabuki syndrome (implicated_via_orthology)	KDM6A UTY	3.61e-05	3	103	2	DOID:0060473 (implicated_via_orthology)
Disease	alcohol use disorder (implicated_via_orthology)	KDM3A KDM3B CTSL CTSV KDM6A UTY	6.48e-05	195	103	6	DOID:1574 (implicated_via_orthology)
Disease	NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement	CFHR4 CFHR3	7.21e-05	4	103	2	EFO_0803292
Disease	nephrotic syndrome (biomarker_via_orthology)	VLDLR CTSL CTSV	7.93e-05	24	103	3	DOID:1184 (biomarker_via_orthology)
Disease	response to platinum based chemotherapy, cytotoxicity measurement	FRAS1 EYS	1.20e-04	5	103	2	EFO_0004647, EFO_0006952
Disease	lung small cell carcinoma (is_implicated_in)	FAT1 MTOR KDM6A	1.27e-04	28	103	3	DOID:5409 (is_implicated_in)
Disease	Glioblastoma	FAT1 MTOR JAG1 CTSK	1.72e-04	79	103	4	C0017636
Disease	obesity	ZC3H11B PRAG1 FAT1 NRXN3 PRDM16 KLRB1	2.06e-04	241	103	6	EFO_0001073
Disease	Giant Cell Glioblastoma	FAT1 MTOR JAG1 CTSK	2.18e-04	84	103	4	C0334588
Disease	Acute Confusional Migraine	LRP1 PRDM16	4.28e-04	9	103	2	C0521664
Disease	Status Migrainosus	LRP1 PRDM16	4.28e-04	9	103	2	C0338489
Disease	Atypical hemolytic-uremic syndrome	CFHR4 CFHR3	4.28e-04	9	103	2	cv:C2931788
Disease	Abdominal Migraine	LRP1 PRDM16	4.28e-04	9	103	2	C0270858
Disease	Hemolytic-uremic syndrome	CFHR4 CFHR3	4.28e-04	9	103	2	cv:C0019061
Disease	Sick Headaches	LRP1 PRDM16	4.28e-04	9	103	2	C0700438
Disease	Cervical Migraine Syndrome	LRP1 PRDM16	4.28e-04	9	103	2	C0007852
Disease	Hemicrania migraine	LRP1 PRDM16	4.28e-04	9	103	2	C0018984
Disease	progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma	DAPK1 EYS PRDM16	4.30e-04	42	103	3	EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354
Disease	Malignant Head and Neck Neoplasm	APOBEC3B FANCC FAT1	4.93e-04	44	103	3	C0278996
Disease	Glioblastoma Multiforme	FAT1 MTOR JAG1 CTSK	6.30e-04	111	103	4	C1621958
Disease	Ashkenazi Jewish disorders	ELP1 FANCC	6.50e-04	11	103	2	cv:CN118946
Disease	colorectal cancer (is_implicated_in)	RBM10 LRP1B FAT1 KDM6A	8.70e-04	121	103	4	DOID:9256 (is_implicated_in)
Disease	Migraine Disorders	LRP1 PRDM16	9.18e-04	13	103	2	C0149931
Disease	Antithrombotic agent use measurement	TMEM91 FANCC PRDM8	9.50e-04	55	103	3	EFO_0009925
Disease	Left ventricular noncompaction	MIB1 PRDM16	1.07e-03	14	103	2	C1960469
Disease	Malignant Neoplasms	APOBEC3B MTOR LTF KDM6A	1.07e-03	128	103	4	C0006826
Disease	1,3,7-trimethylurate measurement	CYP1A2 FRAS1	1.23e-03	15	103	2	EFO_0021172
Disease	lung non-small cell carcinoma (is_implicated_in)	LRP1B FAT1 LTF KDM6A	1.45e-03	139	103	4	DOID:3908 (is_implicated_in)
Disease	Bladder Neoplasm	APOBEC3B FANCC MTOR KDM6A	1.49e-03	140	103	4	C0005695
Disease	Malignant neoplasm of urinary bladder	APOBEC3B FANCC MTOR KDM6A	1.53e-03	141	103	4	C0005684
Disease	Familial Progressive Myoclonic Epilepsy	PRDM8 SACS	1.59e-03	17	103	2	C0751777
Disease	Atypical Inclusion-Body Disease	PRDM8 SACS	1.59e-03	17	103	2	C0751776
Disease	Myoclonic Epilepsies, Progressive	PRDM8 SACS	1.59e-03	17	103	2	C0751778
Disease	Biotin-Responsive Encephalopathy	PRDM8 SACS	1.59e-03	17	103	2	C0751780
Disease	May-White Syndrome	PRDM8 SACS	1.59e-03	17	103	2	C0751782
Disease	Dentatorubral-Pallidoluysian Atrophy	PRDM8 SACS	1.59e-03	17	103	2	C0751781
Disease	Benign Neoplasm	APOBEC3B LTF KDM6A	1.76e-03	68	103	3	C0086692
Disease	Neoplasms	APOBEC3B LTF KDM6A	1.76e-03	68	103	3	C0027651
Disease	bipolar disorder, sex interaction measurement	ADGRB1 SLIT1	1.78e-03	18	103	2	EFO_0008343, MONDO_0004985
Disease	Action Myoclonus-Renal Failure Syndrome	PRDM8 SACS	1.78e-03	18	103	2	C0751779
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	DAPK1 LRP1B MTOR KDM6A	1.83e-03	148	103	4	C0279702
Disease	Antimigraine preparation use measurement	LRP1 PRDM16	2.43e-03	21	103	2	EFO_0009939
Disease	dilated cardiomyopathy (implicated_via_orthology)	JAG1 CTSL CTSV	2.79e-03	80	103	3	DOID:12930 (implicated_via_orthology)
Disease	hematocrit	VLDLR ZAN PGAP6 STAB1 FANCC PRDM8 FAT1 JAG1 PLCL2 PRDM16	2.84e-03	1011	103	10	EFO_0004348
Disease	leptin measurement	LRP1B NRXN3 SLIT1	2.89e-03	81	103	3	EFO_0005000
Disease	Cancer of Head	APOBEC3B FAT1	3.17e-03	24	103	2	C0751177
Disease	Head Neoplasms	APOBEC3B FAT1	3.17e-03	24	103	2	C0018675
Disease	Upper Aerodigestive Tract Neoplasms	APOBEC3B FAT1	3.17e-03	24	103	2	C0887900
Disease	Neck Neoplasms	APOBEC3B FAT1	3.44e-03	25	103	2	C0027533
Disease	corpus collosum mid-posterior volume measurement	VLDLR JAG1	3.44e-03	25	103	2	EFO_0010300
Disease	Cancer of Neck	APOBEC3B FAT1	3.44e-03	25	103	2	C0746787

Protein segments in the cluster

Peptide	Gene	Start	Entry
YVTPVKNQGQCGSCW	CTSK	126	P43235
VICQKNLRWTPYQGC	C4BPA	346	P04003
PCGIFHKVQVNLCRW	DAPK1	1141	P53355
CGNQLPAYKCFQITW	APOBEC3B	76	Q9UH17
FAPSQICLQWITQCF	TBC1D32	1151	Q96NH3
TRDCFLQQCPVDGKW	ADGRB1	511	O14514
VTPVKNQKQCGSCWA	CTSV	126	O60911
IKVWAIACFAPQKQC	AGO1	446	Q9UL18
PYQCLGARKLCQCQW	C17orf78	211	Q8N4C9
KVWAVACFAPQKQCR	AGO4	441	Q9HCK5
ALTNNPWKCTCQLRG	CHAD	296	O15335
CLVVFKPIWCQNHRN	C3AR1	121	Q16581
NRGNCWIINNCKTKC	RAD51AP2	406	Q09MP3
PKINEDWLCNKCGVQ	RBM10	211	P98175
IPKKCCVFVNQWQVN	CYP1A2	401	P05177
LNVFQKLCAGLDCPW	FAT1	3731	Q14517
DLCQDPTKLLQNGWC	FRAS1	436	Q86XX4
DQFRCSNGQCIPAKW	LRP1B	3556	Q9NZR2
PCKNNGSCINKRENW	EYS	221	Q5T1H1
WSCQLPCGQKLLCGQ	NFXL1	306	Q6ZNB6
ICTNFRVTFQPCGWQ	MTMR11	71	A4FU01
ASQFVCKNDKCIPFW	LRP1	3336	Q07954
CEDICWIKTNKNNPG	METTL14	256	Q9HCE5
TRKNCAQLWLGPAAF	KMT5B	256	Q4FZB7
NIAWNVGPLTACQYK	KDM6A	1236	O15550
GECWCVNPNTGKLIQ	IGFBP2	281	P18065
SGFVCNTCPEKWINF	FCER2	156	P06734
LKEPENCNNFCLWKQ	NRDE2	771	Q9H7Z3
PCKNNAVCKDGWNRF	NRXN3	651	Q9Y4C0
CIDLWLKNNSQCPAC	OBI1	41	Q5W0B1
GKWGIKANCPCISRQ	KDM3B	1116	Q7LBC6
LWLSLAKNCFAPQCP	LRRC71	516	Q8N4P6
CSEQWIPFQNKCFLK	LY75	951	O60449
GCPSDWIQFLNKCFQ	MRC2	971	Q9UBG0
LETLFLSGNPWKCNC	LRRC52	176	Q8N7C0
AFLTCGNWKQALCVA	ELP1	1021	O95163
CSLLQGFWCQPASQL	MSLNL	56	Q96KJ4
NFQKVLTCTGAPWPC	PGAP6	251	Q9HCN3
ANSNPWECNCKLLGL	LRRC70	356	Q7Z2Q7
QPIIGIRWKCAECTN	MIB1	91	Q86YT6
FVNWKCCFIPLTIPN	GPR160	311	Q9UJ42
CIIDQFICPGQAKWV	OGDH	756	Q02218
KPGQLINWFICSLCV	GASK1B	6	Q6UWH4
CIRFWNTLTGQPLQC	FZR1	381	Q9UM11
LWVSCANGQVKPCDF	CFHR3	11	Q02985
TCLQNGWSAQPICIN	CFHR3	191	Q02985
VRAKWGIKANCPCSN	KDM3A	741	Q9Y4C1
WERPCFQAHLGCLQN	LINC01555	71	Q8NAE3
QLNKCPACFGTSWCR	DIPK2A	51	Q8NDZ4
IWCLCCLINKEPQNS	FANCC	91	Q00597
ISPIKDQKNCNCCWA	CTSW	141	P56202
QNGWSTQPICIKFCD	CFHR4	136	Q92496
CLQNGWSAQPICIKF	CFHR4	381	Q92496
TVLTCKCQNCFPLNW	EMB	176	Q6PCB8
VNCIQWICKQDGSPS	ELP2	61	Q6IA86
KQGIFQLWNCPLNEG	FAM217A	81	Q8IXS0
FKQCDVLQLLWTSCP	SACS	3691	Q9NZJ4
QKAQWTVGKLNCPFC	RNF180	76	Q86T96
DLVNGFKCVCPPQWT	JAG1	391	P78504
GQLHQQCCEKWTLVN	MTOR	1491	P42345
CNNIAWNVGPLTACQ	UTY	1181	O14607
AICLDNSSGKQPWFC	SPHKAP	946	Q2M3C7
QNPTNCWICLPLNFR	ERVW-1	181	Q9UQF0
NKLCSEVCLPGAWQA	RNF157	631	Q96PX1
CSCDLVGLQQWIQKL	SLITRK6	521	Q9H5Y7
QWCAVSQPEATKCFQ	LTF	26	P02788
NNPWNKLCLVSMDFC	TMEM191A	11	Q9H0A3
SGLFAFNCQCQTWKL	MKLN1	426	Q9UL63
GNWILPKFLCNVAGC	PTAFR	81	P25105
CDQCPKAFNWKSNLI	PRDM16	311	Q9HAZ2
LPAQNWCAKCNASFR	PRDM8	621	Q9NQV8
NMNPQDFWKCGCQIV	PLCL2	686	Q9UPR0
NNFLWKPWLQLCCPS	STS	551	P08842
QLYIASLAWPQNCCV	SMCR5	86	Q8TEV8
FEKNVQGSIPCCFSW	SGMS2	321	Q8NHU3
VTPVKNQGQCGSCWA	CTSL	126	P07711
CKQCGKTFNWPISLR	ZNF555	426	Q8NEP9
KQCGKAFSWPELLQQ	ZNF555	511	Q8NEP9
AALWKLPCIFICENN	PDHA1	211	P08559
LVCTFPAGLWFCIKN	STT3B	421	Q8TCJ2
CYWENQPTGCQKLNC	ZC3H11A	66	O75152
QRWCADPALLNCLKQ	UBR1	1566	Q8IWV7
GCFKQWLKGQSACPA	TTC3	1981	P53804
VCNVGWQGLRCDQKI	STAB1	1401	Q9NY15
WQGLRCDQKITSPQC	STAB1	1406	Q9NY15
LFSLNILGCCQGRNW	VPS45	136	Q9NRW7
PCIQGCHFWNSVDQK	ROS1	56	P08922
CKWNNTGCQALPSQD	PIGR	496	P01833
ENNWSLFKLTCNKPC	PRAG1	986	Q86YV5
TCAKPREQQCGFFQW	TOP3A	921	Q13472
GDNQACKPWTNCTLA	TNFRSF4	136	P43489
CYWENQPTGCQKLNC	ZC3H11B	66	A0A1B0GTU1
LAQNPFICDCNLKWL	SLIT1	436	O75093
PAEQAFWCLVQICEK	TBC1D10A	211	Q9BXI6
WTILNALQKTLQCCG	TSPAN19	141	P0C672
PNFQTLKCRWKNCDA	ZNF106	1841	Q9H2Y7
SCQKCEQPFFWNIKQ	WDFY1	286	Q8IWB7
QSCPGARKCINYQWV	TBRG1	306	Q3YBR2
RVVQKDGNSCAWCPQ	USP6	956	P35125
CQDCKVQGPNLWACL	USP33	61	Q8TEY7
CFWPVGIAAFCLAQK	TMEM91	106	Q6ZNR0
CLKTKGPALWQDNFC	ZNF560	181	Q96MR9
SCKLIQCWGQQEFAI	TMC7	526	Q7Z402
NGFEVQKQNCCWLLV	TYW3	61	Q6IPR3
LQMKFVCGQCWRNGQ	ZC3H7B	691	Q9UGR2
ITCFQSTCKPNQICW	ZAN	1901	Q9Y493
QCAQWLIHCKVLPTN	VAV3	6	Q9UKW4
DFVCNNGQCVPSRWK	VLDLR	76	P98155
LNNLGFKICPCGWHQ	GLYATL2	271	Q8WU03
CQGSPWHQFALKLSC	KLRB1	31	Q12918
TNNWVQCNDAPVKIC	MYOM2	426	P54296